Abnormal expression of MDM-2 in breast carcinomas

Breast Cancer Research and Treatment

Volumn 37, Issue 2, 1996, Pages 179-188

  Bueso Ramos, Carlos E ^a   Manshouri, Taghi ^a   Haidar, Mohammad A ^a   Yang, Yun ^a   McCown, Patrick ^a   Ordonez, Nelson ^b   Glassman, Armand ^a   Sneige, Nour ^b   Albitar, Maher ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Gene amplification; MDM 2 proteins; Oncoprotein; p53; RT PCR

Indexed keywords

MESSENGER RNA; ONCOPROTEIN; PROTEIN P53;

ARTICLE; BREAST CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LEUKEMIA; LYMPHOMA; MESSENGER RNA SYNTHESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SARCOMA; TISSUE CULTURE;

BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; NUCLEAR PROTEINS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030053794     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01806499     Document Type: Article

References (33)

1. Fakharzadeh SS, Trusko SP, George DL: Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J 10: 1565-1569, 1991
2. Momand J, Zambetti GP, Olson DC, George DL, Levine AJ: The MDM-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69: 1237-1245, 1992
3. Barak Y, Juven T, Haffner R, Oren M: MDM2 expression is induced by wild type p53 activity. EMBO J 2: 461-468, 1993
4. Chen J, Marechal V, Levine AJ: Mapping of the p53 and MDM2 interaction domains. Mol Cell Biol 13: 4107-4114, 1993
5. Wu X, Bayle JH, Olson D, Levine AJ: The p53-MDM-2 autoregulatory feedback loop. Genes Dev 7: 1126-1132, 1993
6. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B: Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358: 80-83, 1992
7. Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP: Amplification and overexpression of the MDM-2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res 53: 2736-2739, 1993
8. Leach FS, Tokino T, Meltzer P, Burrel M, Oliner JD, Smith S, Hill DE, Sidransky D, Kinzler KW, Vogelstein B: p53 mutation and MDM-2 amplification in human soft tissue sarcomas. Cancer Res 53: 2231-2234, 1993
9. Cordon-Cardo C, Latres E, Drobnjak M, Oliva M, Pollack D, Woodruff J, Marechal V, Chen J, Brennan M, Levine AJ: Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res 54: 794-799, 1994
10. Patterson H, Gill S, Fisher C, Law MG, Jayatilake H, Fletcher CDM, Thomas M, Grimer R, Gusterson BA, Cooper CS: Abnormalities of the p53, MDM2 and DCC genes in human leiomyosarcomas. Br J Cancer 69: 1052-1058, 1994
11. Finlay CA: The mdm2 oncogene can overcome wild-type p53 suppression of transformed cell growth. Mol Cell Biol 13: 301-306, 1993
12. Bucso-Ramos CE, Yang Y, deLeon E, McCown P, Stass SA, Albitar M: The human MDM-2 oncogene is overexpressed in leukemias. Blood 82: 2617-2623, 1993
13. Bueso-Ramos CE, Manshouri T, Haidar MA, Huh YO, Keating MJ, Albitar M: Multiple patterns of MDM-2 deregulation in human leukemias: Implications in leukemogenesis and prognosis. Leuk Lymphoma (in press)
14. Quesnel B, Preudhomme C, Oscier D, Lepelley P, O'Hooghe CM, Facon T, Zandecki M, Fenaux P: Overexpression of the MDM-2 gene is found in some cases of haematological malignancies. Br J Haematol 88: 415-418, 1994
15. Watanabe T, Hotta T, Ichikawa A, Kinoshita T, Nagai H, Uchida T, Murate T, Saito H: The MDM-2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin. Blood 84: 3158-3165, 1994
16. Sheikh MS, Shao ZM, Hussain A, Fontana JA: The p53-binding protein MDM-2 gene is differentially expressed in human breast carcinoma. Cancer Res 53: 3226-3228, 1993
17. Davidoff AM, Humphrey PA, Iglehart JD, Marks JR: Genetic basis for p53 overexpression in human breast cancer. Proc Natl Acad Sci USA 88: 5006-5010, 1991
18. Harris CC, Hollstein M: Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 329: 1318-1327, 1993
19. Barnes DM, Dublin EA, Fisher CJ, Levison DA, Millis RR: Immunohistochemical detection of p53 protein in mammary carcinoma: An important new independent indicator of prognosis? Hum Pathol 24: 469-476, 1993
20. Poller DN, Roberts EC, Bell JA, Elston CW, Blamey RW, Ellis IO: p53 protein expression in mammary ductal carcinoma in situ: Relationship to immunohistochemical expression of estrogen and c-erbB-2 protein. Hum Pathol 24: 463-468, 1993
21. Black MM, Barclay THC, Hankey BF: Prognosis in breast cancer utilizing histologic characteristics of the primary tumor. Cancer 36: 2048-2055, 1975
22. Sambrook T, Fritsh E, Maniatis T: Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory, Plainview, New York, 1989
23. Hsu SM, Fancer H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and the unlabeled antibody (PAP) procedures. J Histochem Cytochem 29: 177-580, 1981
24. Shi SR, Key MH, Halra KL: Antigen retrieval in formalin-fixed paraffin embedded tissue: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39: 741-748, 1991
25. Vojtesek B, Bártek J, Midgley CA, Lane DP: An immunochemical analysis of the human nuclear phosphoprotein p53: New monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Methods 151: 237-244, 1992
26. Albitar M, Peschle C, Liebhaber SA: Theta, zeta and epsilon globin mRNAs are expressed in normal adults. Blood 74: 629-637, 1989
27. Albitar M, Katsumata M, Liebhaber SA: Human α-globin genes demonstrate autonomous developmental regulation in transgenic mice, Mol Cell Biol 11: 3786-3794, 1991
28. Estes PA, Cook NE, Liebhaber SA: A difference in splicing patterns of the closely related normal and variant human growth hormone gene transcripts is determined by a minimal sequence divergence between two potential splice-acceptor sites. J Biol Chem 265: 19863-19870, 1990
29. Davidson NE: Biology of breast cancer and its clinical implications. Curr Opin Oncol 4: 1003-1009, 1992
30. Koopmans LH: An Introduction to Contemporary Statistics. PWS, Boston, MA, 1981
31. Olson DC, Marechal V, Momand J, Chen J, Komocki C, Levine AJ: Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes, Oncogene 8: 2352-2360, 1993
32. Otto A, Deppert W: Upregulation of MDM2 expression in METU A tumor cells tolerating wild-type p53. Oncogene 8: 2591-2603, 1993
33. Boddy MN, Freeman PS, Borden KLB: The p53-associated protein MDM-2 contains a newly characterized zinc-binding domain called the RING finger. TIBS 19: 198-199, 1994